Cargando…
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Autores principales: | Liu, Xin, Wang, Xiu-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128649/ https://www.ncbi.nlm.nih.gov/pubmed/32173287 http://dx.doi.org/10.1016/j.jgg.2020.02.001 |
Ejemplares similares
-
DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease
por: Shahab, Siyamak, et al.
Publicado: (2021) -
Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020) -
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020) -
2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Liu, Peng, et al.
Publicado: (2020) -
Containing 2019-nCoV (Wuhan) coronavirus
por: Kaplan, Edward H.
Publicado: (2020)